Caricamento...
Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality and health care expenditure throughout the world. COPD guidelines recommend the use of long-acting muscarinic antagonist (LAMA) either alone or in combination with a long-acting β(2) agonist (LABA). For over 10 y...
Salvato in:
| Pubblicato in: | Ther Adv Chronic Dis |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5406010/ https://ncbi.nlm.nih.gov/pubmed/28491268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622317700822 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|